[HTML] thieme-connect.com

[HTML][HTML] The number of concomitant drugs and the safety of direct oral anticoagulants in routine care patients with atrial fibrillation

CJ van den Dries, S van Doorn, P Souverein… - TH Open, 2020 - thieme-connect.com
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …
被引用次数：12 相关文章

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.

CJ van den Dries, S van Doorn… - TH Open: Companion …, 2020 - europepmc.org
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

CJ van den Dries, S van Doorn… - … to thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …
[PDF] core.ac.uk

[PDF][PDF] The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

CJ van den Dries, S van Doorn, P Souverein… - 2020 - core.ac.uk
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …
[PDF] umcutrecht.nl

[PDF][PDF] The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

CJ van den Dries, S van Doorn, P Souverein… - 2020 - researchinformation.umcutrecht.nl
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …
[HTML] nih.gov

[HTML][HTML] The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

CJ van den Dries, S van Doorn… - TH Open: Companion …, 2020 - ncbi.nlm.nih.gov
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists
(VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with …